SK Biopharmaceuticals. (326030.KQ) Q2 2026 Earnings

7MayConfirmed
Q3 2025
Q4 2025
Q1 2026
Next
349.08
802.9
1,256.71
1,710.53

Details

Expected EPS
471.446355144
Actual EPS
N/A
Surprise EPS
-471.45
Surprise Percent
+100%

Description

SK Biopharmaceuticals. (326030.KQ) will report earnings of for Q2 2026 on May 07, 2026.

0 Comments

Share your thoughts